DEA Marijuana Rescheduling Likely By Next Year

WASHINGTON DC – A former Food and Drug Administration official says he’d be “shocked” if the DEA does not reschedule cannabis by next year’s presidential election, and that he expects the DEA will ultimately accept the recent Health and Human Services’ recommendation to ease restrictions on cannabis by reclassifying it as a Schedule III ... Read More

DEA Delays FDA Sanctioned Marijuana Clinical Trials- Researcher’s Suit Moves To DC Appellate Court – World News Report

“Justice delayed is justice denied,” Duane Boise, the president of MMJ, told Law360 on Thursday. PROVIDENCE, RI / ACCESSWIRE / November 15, 2022 / A Rhode Island federal judge has referred a suit by cannabis researcher MMJ International Holdings Corp. alleging the Drug Enforcement Administration has delayed processing its application ... Read More